UNITED HOSPITAL CENTER
1. Target Overview & Investment Thesis
UNITED HOSPITAL CENTER is a 232-bed suburban community hospital in HARRISON, WV with $516.4M in net patient revenue and a 9.4% operating margin. The hospital serves a payer mix of 31.8% Medicare, 4.7% Medicaid, and 63.5% commercial.
Thesis: Platform Growth. Our ML models identify $38.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 9.4% to 16.8% (+736bps).
| Net Revenue HCRIS | $516.4M |
| Current EBITDA COMPUTED | $48.5M |
| Operating Margin COMPUTED | 9.4% |
| Occupancy HCRIS | 75.5% |
| Revenue / Bed COMPUTED | $2.2M |
| Net-to-Gross HCRIS | 34.3% |
| Distress Probability ML | 42.0% |
2. Market Context & Competitive Position
WV has 62 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 9.4% places it above the state median. Among 12 size-comparable peers (116-464 beds), the median margin is -5.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (116-464), prioritizing same-state peers. 12 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| UNITED HOSPITAL CENTER (Target) | WV | 232 | $516.4M | 9.4% |
| CABELL HUNTINGTON HOSPITAL | WV | 330 | $718.8M | -1.8% |
| ST. MARYS MEDICAL CENTER INC. | WV | 350 | $507.8M | -9.8% |
| WHEELING HOSPITAL | WV | 189 | $411.4M | -8.5% |
| CAMDEN-CLARK MEMORIAL HOSPITAL | WV | 256 | $357.5M | -8.0% |
| CITY HOSPITAL INC. | WV | 163 | $304.2M | -2.8% |
| THOMAS MEMORIAL HOSPITAL | WV | 176 | $209.0M | 26.7% |
| WEIRTON MEDICAL CENTER | WV | 127 | $182.4M | 9.4% |
| RALEIGH GENERAL HOSPITAL | WV | 300 | $181.8M | -6.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $38.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $10.8M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $10.3M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $10.2M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $6.3M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $330K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $48.5M |
| + RCM Uplift | +$38.0M |
| Pro Forma EBITDA | $86.5M |
| Current Margin | 9.4% |
| Pro Forma Margin | 16.8% |
| WC Released (1x) | $19.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $74.7M | $700.2M | 9.38x | 56.5% |
| Base (11x exit) | 10.0x | 11.0x | $74.7M | $794.5M | 10.64x | 60.5% |
| Bull Case | 9.0x | 11.0x | $67.2M | $944.2M | 14.05x | 69.6% |
| Bull (12x exit) | 9.0x | 12.0x | $67.2M | $1.05B | 15.62x | 73.3% |
| Bear Case | 11.0x | 10.0x | $82.1M | $485.9M | 5.92x | 42.7% |
| Bear (11x exit) | 11.0x | 11.0x | $82.1M | $561.2M | 6.83x | 46.9% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 12 hospitals with 116-464 beds
- Same-state prioritization (n=13)
- Comp margins: P25=-8.2% / P50=-5.3% / P75=0.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.